| A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement S Friel, D Gleeson, AM Thow, R Labonte, D Stuckler, A Kay, W Snowdon Globalization and health 9 (1), 46, 2013 | 164 | 2013 |
| Emerging threats to public health from regional trade agreements D Gleeson, S Friel The Lancet 381 (9876), 1507-1509, 2013 | 128 | 2013 |
| Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific … AM Thow, W Snowdon, R Labonté, D Gleeson, D Stuckler, L Hattersley, ... Health Policy 119 (1), 88-96, 2015 | 127 | 2015 |
| Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific … AM Thow, W Snowdon, R Labonté, D Gleeson, D Stuckler, L Hattersley, ... Health Policy, 0 | 127 | |
| Negotiating tensions in developing organizational policy capacity: Comparative lessons to be drawn D Gleeson, D Legge, D O'Neill, M Pfeffer Journal of Comparative Policy Analysis: Research and Practice 13 (3), 237-263, 2011 | 124 | 2011 |
| The high price of “free” trade: US trade agreements and access to medicines R Lopert, D Gleeson Journal of Law, Medicine & Ethics 41 (1), 199-223, 2013 | 117 | 2013 |
| Evaluating health policy capacity: Learning from international and Australian experience DH Gleeson, DG Legge, D O'Neill Australia and New Zealand Health Policy 6 (1), 3, 2009 | 83 | 2009 |
| Evaluating health policy capacity: Learning from international and Australian experience DH Gleeson, DG Legge, D O'Neill Australia and New Zealand Health Policy 6 (1), 3, 2009 | 83 | 2009 |
| A conceptual framework for investigating the impacts of international trade and investment agreements on noncommunicable disease risk factors A Schram, A Ruckert, JA VanDuzer, S Friel, D Gleeson, AM Thow, ... Health policy and planning 33 (1), 123-136, 2018 | 59 | 2018 |
| Policy coherence, health and the sustainable development goals: a health impact assessment of the Trans-Pacific Partnership A Ruckert, A Schram, R Labonté, S Friel, D Gleeson, AM Thow Critical Public Health 27 (1), 86-96, 2017 | 59 | 2017 |
| Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts D Gleeson, J Lexchin, R Labonté, B Townsend, MA Gagnon, J Kohler, ... Globalization and health 15 (1), 78, 2019 | 54 | 2019 |
| How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand D Gleeson, R Lopert, P Reid Health Policy 112 (3), 227-233, 2013 | 52 | 2013 |
| Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health R Labonté, E Crosbie, D Gleeson, C McNamara Globalization and Health 15 (1), 44, 2019 | 50* | 2019 |
| USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health R Labonté, E Crosbie, D Gleeson, C McNamara Globalization and Health 15 (1), 35, 2019 | 50 | 2019 |
| Shaping the discourse: What has the food industry been lobbying for in the Trans Pacific Partnership trade agreement and what are the implications for dietary health? S Friel, S Ponnamperuma, A Schram, D Gleeson, A Kay, AM Thow, ... Critical Public Health 26 (5), 518-529, 2016 | 49 | 2016 |
| What is the impact of intellectual property rules on access to medicines? A systematic review B Tenni, HVJ Moir, B Townsend, B Kilic, AM Farrell, T Keegel, D Gleeson Globalization and health 18 (1), 40, 2022 | 47 | 2022 |
| Governance and policy capacity in health development and implementation in Australia A Hughes, D Gleeson, D Legge, V Lin Policy and Society 34 (3-4), 229-245, 2015 | 45 | 2015 |
| Aboriginal health policy: is nutrition the ‘gap’ in ‘Closing the Gap’? D Browne, Jennifer, Hayes, Rick, Gleeson Australian and New Zealand Journal of Public Health 38 (4), 362-369, 2014 | 41 | 2014 |
| Challenges to Australia’s national health policy from trade and investment agreements TA Faunce Medical Journal of Australia 196 (5), 354-356, 2012 | 40* | 2012 |
| Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement K Hirono, F Haigh, D Gleeson, P Harris, AM Thow, S Friel BMJ open 6 (4), e010339, 2016 | 37 | 2016 |
Ronald LabonteUniversity of Ottawa在 uottawa.ca 的电子邮件经过验证
